Boston Scientific to acquire BTG for $4.2bn

Boston Scientific signed an agreement to acquire UK-based BTG for $4.2bn. The deal is expected to close mid-2019 after antitrust clearance.

“The acquisition is expected to boost Boston Scientific’s capabilities in areas of unmet need such as cancer and pulmonary embolism.”medicaldevice-network.com

• 1 source
• medicaldevice-network.comUS regulator seeks additional details on $4.2bn Boston Scientific-BTG dealDivya TirumalarajuFeb 18, 2019

Summarized from public sources; check the original articles before acting on it.